ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,094, issued on March 17, was assigned to Canole LLC (Shreveport, La.).
"Combination cannabinoid-phenylethanoid formulation for treatment of inflammation and methods related thereto" was invented by David Bradley Schmidt (Shreveport, La.), Alana L. Gray (Keithville, La.) and David T. Coleman (Keithville, La.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention describes cannabinoid formulations that combine cannabinoids, such as CBD, with other active agents within the phenylethanoid class of compounds, such as oleocanthal, which, in combination, provide synergistic anti-inflammatory effects. These combination preparations are capabl...